Marcellin P - Search Results

1

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.

Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. Bièche I, et al. Among authors: marcellin p. Pharmacogenet Genomics. 2007 Sep;17(9):731-42. doi: 10.1097/FPC.0b013e32810f2e58. Pharmacogenet Genomics. 2007. PMID: 17700362

2

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

Asselah T, Marcellin P. Asselah T, et al. Among authors: marcellin p. Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x. Liver Int. 2011. PMID: 21205141 Review.

3

Viral hepatitis: impressive advances but still a long way to eradication of the disease.

Marcellin P, Asselah T. Marcellin P, et al. Liver Int. 2014 Feb;34 Suppl 1:1-3. doi: 10.1111/liv.12422. Liver Int. 2014. PMID: 24373070 No abstract available.

4

Viral hepatitis: towards the eradication of HCV and a cure for HBV.

Asselah T, Marcellin P. Asselah T, et al. Among authors: marcellin p. Liver Int. 2015 Jan;35 Suppl 1:1-3. doi: 10.1111/liv.12744. Liver Int. 2015. PMID: 25529080 No abstract available.

5

Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir.

Asselah T, Marcellin P. Asselah T, et al. Among authors: marcellin p. Liver Int. 2014 Feb;34 Suppl 1:60-8. doi: 10.1111/liv.12424. Liver Int. 2014. PMID: 24373080 Review.

6

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.

Estrabaud E, Lapalus M, Broët P, Appourchaux K, De Muynck S, Lada O, Martinot-Peignoux M, Bièche I, Valla D, Bedossa P, Marcellin P, Vidaud M, Asselah T. Estrabaud E, et al. Among authors: marcellin p. J Virol. 2014 Jun;88(11):6394-402. doi: 10.1128/JVI.00016-14. Epub 2014 Mar 26. J Virol. 2014. PMID: 24672032 Free PMC article.

7

Acute hepatitis E with severe jaundice: report of three cases.

Moucari R, Bernuau J, Nicand E, Cazals-hatem D, Valla D, Marcellin P, Asselah T. Moucari R, et al. Among authors: marcellin p. Eur J Gastroenterol Hepatol. 2007 Nov;19(11):1012-5. doi: 10.1097/MEG.0b013e328209414d. Eur J Gastroenterol Hepatol. 2007. PMID: 18049173

8

[Hepatitis B: clinical application of HBsAg quantification].

Martinot-Peignoux M, Marcellin P, Asselah T. Martinot-Peignoux M, et al. Among authors: marcellin p. Ann Biol Clin (Paris). 2013 Nov;71:19-26. doi: 10.1684/abc.2013.0898. Ann Biol Clin (Paris). 2013. PMID: 24235324 Review. French.

9

Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow.

Asselah T, Marcellin P. Asselah T, et al. Among authors: marcellin p. Liver Int. 2012 Feb;32 Suppl 1:88-102. doi: 10.1111/j.1478-3231.2011.02699.x. Liver Int. 2012. PMID: 22212578 Review.

10

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection.

Asselah T, Marcellin P. Asselah T, et al. Among authors: marcellin p. Liver Int. 2015 Jan;35 Suppl 1:56-64. doi: 10.1111/liv.12745. Liver Int. 2015. PMID: 25529088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page